info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
Indian Flag  IN: +91-826-083-6500
Home » therapeutics

therapeutics

Myelofibrosis Market By Therapy Class (JAK Inhibitors, Antifibrotic Agents, Immunotherapies, Telomerase Inhibitors); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail & Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Myelofibrosis Market valued at USD 1.8 billion in 2024 and projected to reach USD 3.4 billion by 2030 at 10.5% CAGR, driven by rare disease treatm... Read More

Published Date: JAN-2026 | No Of Pages:168 | $ 4485

Endocrine Disorders Market By Disorder Type (Diabetes, Thyroid Disorders, Adrenal Disorders, PCOS & Reproductive Endocrine Disorders, Rare Endocrine Disorders); By Treatment Modality (Pharmaceuticals, Medical Devices & Monitoring Tools, Surgical Interventions, Lifestyle & Digital Interventions); By End User (Hospitals & Specialty Clinics, Ambulatory & Outpatient Centers, Homecare & Remote Monitoring, Diagnostic Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Endocrine Disorders Market: Metabolic Scale, Diagnostic Expansion, and Rare-Disease Innovation Reshape Commercial Growth

The Global Endocrine Disorders Market was valued at USD 103.80 billion in 2025 and is projected to reach USD 158.15 billion by 2032, expanding at a... Read More

Published Date: AUG-2026 | No Of Pages:173 | $ 4485

Laryngeal Cancer Therapeutics Market By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Surgery); By Route of Administration (Oral, Intravenous, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Laryngeal Cancer Therapeutics Market projected to reach USD 4.1 billion by 2030 from USD 2.6 billion in 2024, registering 6.8% CAGR, supported by ... Read More

Published Date: JAN-2026 | No Of Pages:187 | $ 4485

Fascioliasis Market By Product Type (Antiparasitic Drugs, Diagnostics, Supportive & Biliary Complication Management, Emerging Second-Line Therapies); By Drug Type (Triclabendazole, Nitazoxanide and Other Off-Label Antiparasitic Drugs, Pipeline and Investigational Therapies); By Diagnostic Modality (Serology, Stool Microscopy, Molecular and Antigen-Based Tests, Bloodwork and Liver Function Testing, Ultrasound, CT and MRI Imaging); By End User (Public Health Agencies and International Treatment Programs, Hospitals and Rural Health Centers, Diagnostic Laboratories, Specialty Gastroenterology and Infectious Disease Centers); By Region (Latin America, Asia-Pacific, Middle East and Africa, Europe and North America); Segment Revenue Estimation, Forecast, 2026–2032

Fascioliasis Market: Diagnostic Gaps and Single-Drug Dependence Shape Revenue Growth

The Global Fascioliasis Market is valued at approximately USD 420 million in 2025 and is projected to reach USD 623 million by 2032, expanding at a CAGR of 5.79%, according to Strateg... Read More

Published Date: JUL-2026 | No Of Pages:156 | $ 4485

Immune Thrombocytopenia (ITP) Market By Drug Class (Thrombopoietin Receptor Agonists, FcRn Inhibitors, Monoclonal Antibodies, Syk Inhibitors, Others); By Route of Administration (Oral, Parenteral, Subcutaneous); By End User (Hospitals, Specialty Hematology Clinics, Retail & Specialty Pharmacies, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Immune Thrombocytopenia (ITP) Market is projected to grow at a CAGR of 6.8%, valued at approximately USD 2.5 billion in 2024 and expected to reach nearly USD 3.9 b... Read More

Published Date: JAN-2026 | No Of Pages:196 | $ 4485

Visceral Pain Treatment Market By Treatment Type (Gastrointestinal Prescription Therapies, Hormonal and GnRH-Based Therapies, Analgesics and Supportive Drug Therapies, Neuromodulation Devices, Bladder Pain Therapies, Organ-Directed Procedures and Other Treatments); By Indication (Irritable Bowel Syndrome, Endometriosis-Associated Pain, Interstitial Cystitis/Bladder Pain Syndrome, Functional Abdominal Pain, Chronic Pancreatitis, Cancer-Related Visceral Pain, Other Visceral Pain Conditions); By End User (Hospitals, Gastroenterology Centers, Gynecology and Women’s Health Clinics, Urology Clinics, Pain Management Clinics, Pediatric Specialty Clinics, Others); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Visceral Pain Treatment Market Benefits from IBS Drug Demand, Endometriosis Access Expansion, and Organ-Specific Non-Opioid Development

The Global Visceral Pain Treatment Market was valued at USD 16.4 billion in 2025 and is projected to reach USD 24.35 billion by 2032... Read More

Published Date: JUL-2026 | No Of Pages:180 | $ 4485

Erythroid Maturation Agent Market By Drug Type (Luspatercept, Next-Gen Ligand Traps, Experimental SMAD Modulators); By Indication (Transfusion-Dependent Beta-Thalassemia, Myelodysplastic Syndromes, Others); By Route of Administration (Subcutaneous, Oral [Pipeline]); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Erythroid Maturation Agent Market projected to reach USD 1.65 billion by 2030 from USD 1.12 billion in 2024, registering 6.5% CAGR, supported by b... Read More

Published Date: JAN-2026 | No Of Pages:187 | $ 4485

Temporal Arteritis Market By Treatment Type (Corticosteroids, Biologics [IL-6 Inhibitors, JAK Inhibitors, Others]); By Diagnostic Modality (Temporal Artery Biopsy, Ultrasound, MRI Angiography, PET-CT); By End User (Hospitals, Specialty Clinics, Diagnostic Centers, ASCs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Temporal Arteritis Market valued at USD 1.4 billion in 2024 and projected to reach USD 2.0 billion by 2030 at 5.8% CAGR, driven by autoimmune diso... Read More

Published Date: JAN-2026 | No Of Pages:171 | $ 4485

Hemorrhagic Stroke Treatment Market By Treatment Type (Drug Therapy, Surgical Intervention, Endovascular Procedures, Monitoring & Supportive Devices); By Cause/Condition (Intracerebral Hemorrhage, Subarachnoid Hemorrhage, Other Rare Hemorrhages); By End User (Tertiary Hospitals, General Hospitals, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Hemorrhagic Stroke Treatment Market Scales Through ICU Severity, Aneurysm Repair, and Selective Device Evidence

The Global Hemorrhagic Stroke Treatment Market was valued at USD 4.12 billion in 2025 and is projected to reach USD 6.27 billion by 2032, growing at a CAGR ... Read More

Published Date: JUL-2026 | No Of Pages:175 | $ 4485

Dilated Cardiomyopathy Market By Therapy (Pharmacological Treatments, Novel & Targeted Therapies); By Device (ICDs & CRT-Ds, LVADs, Wearable Monitoring Devices); By Diagnostic Approach (Echocardiography, Cardiac MRI, Genetic Testing); By End User (Hospitals & Cardiac Centers, Specialty Clinics, Diagnostic Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dilated Cardiomyopathy Market valued at USD 2.9 billion in 2024 and reaching USD 4.6 billion by 2030 at 7.9% CAGR, driven by cardiovascular diseas... Read More

Published Date: JAN-2026 | No Of Pages:198 | $ 4485

IgG4-Related Disease Market By Treatment Type (Corticosteroids, Immunosuppressive Drugs, Biologics, Small Molecules); By Diagnostic Method (Serological Testing, Imaging, Biopsy, Digital Pathology, Biomarker Panels); By End User (Tertiary Care Hospitals, Specialty Clinics, Reference Laboratories, Academic & Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global IgG4-Related Disease Market valued at USD 2.1 billion in 2024 and projected to reach USD 3.5 billion by 2030 at 7.5% CAGR, driven by rare disease ... Read More

Published Date: JAN-2026 | No Of Pages:187 | $ 4485

Budesonide Inhaler Market By Product Type (Dry Powder Inhalers, Metered Dose Inhalers, Nebulized Suspensions); By Indication (Asthma, Chronic Obstructive Pulmonary Disease, Allergic Rhinitis, Others); By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Budesonide Inhaler Market valued at USD 2.36 billion in 2024 and projected to reach USD 3.31 billion by 2030 at 5.8% CAGR, driven by asthma treatm... Read More

Published Date: JAN-2026 | No Of Pages:169 | $ 4485

Inhaled Nitric Oxide Market By Application (Neonatal Respiratory Failure, ARDS, Post-Operative Cardiac Surgery, Organ Transplantation, COPD & Interstitial Lung Diseases); By Delivery System (Standalone Hospital Systems, Transport/Portable Units, Integrated Ventilator Modules); By End User (Neonatal & Pediatric ICUs, Adult ICUs, Cardiothoracic Surgery Centers, Emergency Medical & Transport Teams); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Inhaled Nitric Oxide Market valued at USD 980 million in 2024 and projected to reach USD 1.41 billion by 2030 at 6.3% CAGR, driven by neonatal car... Read More

Published Date: JAN-2026 | No Of Pages:175 | $ 4485

Childhood Absence Epilepsy Treatment Market By Drug Class (First-Line Antiepileptic Drugs, Second-Line/Add-On Therapies); By Route of Administration (Oral Solid, Oral Liquid, Others); By End User (Hospitals & Specialty Clinics, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Childhood Absence Epilepsy (CAE) Treatment Market is projected to reach $2.34 billion by 2030 , growing from an estimated $1.48 billion in 2024Read More

Published Date: JAN-2026 | No Of Pages:200 | $ 4485

Supraventricular Tachycardia Treatment Market By Treatment Type (Acute Self-Administered Prescription Therapies, Hospital-Administered Acute Drugs, Chronic Oral Pharmacotherapy, Catheter Ablation, Electrical Cardioversion); By Application (Paroxysmal Supraventricular Tachycardia, Atrioventricular Nodal Re-entrant Tachycardia, Atrioventricular Re-entrant Tachycardia, Wolff-Parkinson-White Syndrome-Associated SVT, Focal Atrial Tachycardia, Recurrent Symptomatic SVT, Pediatric Supraventricular Tachycardia); By End User (Hospitals and Emergency Departments, Cardiology Clinics, Electrophysiology Centres, Ambulatory Surgical Centres, Retail Pharmacies, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Supraventricular Tachycardia Treatment Market: Outpatient Episode Control Redirects Revenue from Emergency Care to Prescription and Ablation Channels

The Global Supraventricular Tachycardia Treatment Market was valued at USD 4.99 billion in 2025 and is projected to re... Read More

Published Date: JUL-2026 | No Of Pages:177 | $ 4485

Viral Gastroenteritis Market By Product Type (Diagnostics, Vaccines, Therapeutics, Oral Rehydration); By Virus Type (Rotavirus, Norovirus, Adenovirus, Astrovirus, Sapovirus); By End User (Hospitals, Clinics, Diagnostic Labs, Home Users); By Geography, Segment Revenue Estimation, Forecast, 2025–2030

Introduction And Strategic Context

The Global Viral Gastroenteritis Market valued at USD 6.1 billion in 2024 and projected to reach USD 8.9 billion by 2030 at 6.5% CAGR, driven by infectious d... Read More

Published Date: JAN-2026 | No Of Pages:155 | $ 4485

Therapeutic Proteins and Oral Vaccines Market By Product Type (Monoclonal Antibodies, Recombinant Hormones & Growth Factors, Enzyme Replacement Therapies, Interferons, Oral Vaccines); By Route of Administration (Oral, Intravenous, Subcutaneous, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Therapeutic Proteins and Oral Vaccines Market valued at USD 165.7 billion in 2024 and projected to reach USD 280.6 billion by 2030 at 7.9% CAGR, driven by... Read More

Published Date: JAN-2026 | No Of Pages:181 | $ 4485

Oligodendroglioma Market By Treatment Type (Surgical Resection, Chemotherapy, Radiotherapy, Targeted Therapy); By Tumor Grade (Grade II, Grade III); By End User (Tertiary Hospitals, Cancer Specialty Centers, Private Hospitals, Community Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Oligodendroglioma Market is projected to grow at a steady CAGR of 8.0% , moving from an estimated USD 421.6 million in 2024 to around Read More

Published Date: JAN-2026 | No Of Pages:197 | $ 4485

Cryptococcosis Market By Treatment Type (Amphotericin B, Flucytosine, Azole Antifungals, Emerging Therapies); By Infection Type (Cryptococcal Meningitis, Pulmonary Cryptococcosis, Cutaneous & Disseminated Forms); By End User (Hospitals & Specialty Clinics, Community Clinics, Pharmacies, NGO/Government Programs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cryptococcosis Market valued at USD 6.2 billion in 2024 and projected to reach USD 8.7 billion by 2030 at 5.8% CAGR, driven by antifungal therapy<... Read More

Published Date: JAN-2026 | No Of Pages:199 | $ 4485

Ankylosing Hyperostosis Market By Treatment Type (Pharmacological Therapy, Physical Therapy & Rehabilitation, Surgical Intervention, Lifestyle & Nutritional Management); By Diagnosis Modality (X-ray, CT, MRI); By End User (Hospitals & Specialty Clinics, Rehabilitation Centers, Imaging Centers, Home Health Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ankylosing Hyperostosis Market is projected to expand steadily, valued at USD 1.2 billion in 2024 and forecasted to reach USD 1.9 billion by 2030 , growin... Read More

Published Date: JAN-2026 | No Of Pages:193 | $ 4485

Acquired Methemoglobinemia Market By Therapeutic Type (Methylene Blue, Ascorbic Acid, Hyperbaric Oxygen Therapy, Others); By Diagnostic Method (Co-oximetry, Point-of-Care Devices, Laboratory Testing); By End User (Hospitals, Specialty Clinics, Diagnostic Laboratories, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acquired Methemoglobinemia Market will witness a robust CAGR of 8.5%, valued at USD 1.1 billion in 2024 , expected to appreciate and reach USD 1.8... Read More

Published Date: JAN-2026 | No Of Pages:162 | $ 4485

Acrodysostosis Treatment Market By Treatment Type (Hormone Therapy, Orthopedic Surgery, Anti-inflammatory Medications, Experimental Therapies); By Route of Administration (Oral, Injectable, Surgical); By End User (Tertiary Hospitals, Specialty Clinics, Academic & Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acrodysostosis Treatment Market is projected to grow at a CAGR of 6.4%, with an estimated market size of USD 412 million in 2024 and a fo... Read More

Published Date: JAN-2026 | No Of Pages:173 | $ 4485

Flavimonas Oryzihabitans Infection Market By Product & Service (Blood-Culture Instruments and Consumables, Automated Microbial-Identification Systems, MALDI-TOF Platforms, Antimicrobial Susceptibility-Testing Systems, Molecular Sequencing and Strain-Typing Services, Systemic Antibacterial Drugs, Catheter Removal and Replacement Services); By Application (Catheter-Related Bloodstream Infections, Primary Bacteremia, Peritoneal Dialysis-Associated Peritonitis, Catheter Exit-Site and Tunnel Infections, Prosthetic and Implanted-Device Infections, Wound and Soft-Tissue Infections, Environmental Contamination and Pseudo-Outbreak Investigations); By End User (Tertiary and Academic Hospitals, Hospital Microbiology Laboratories, Oncology and Hematology Centers, Dialysis and Nephrology Providers, Transplant and Intensive-Care Units, Reference and Molecular Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Flavimonas Oryzihabitans Infection Market: Rare Catheter-Linked Cases Support Demand for Rapid Diagnostics and Hospital Source Control

The Global Flavimonas Oryzihabitans Infection Market is estimated to reach USD 708.68 million in 2025Read More

Published Date: JUL-2026 | No Of Pages:194 | $ 4485

Human Granulocytic Ehrlichiosis Market By Product Type (Diagnostics, Therapeutics); By Diagnostic Method (PCR, ELISA, Immunofluorescence Assays, Next-Generation Sequencing); By End User (Hospitals, Clinics, Reference Laboratories, Public Health Agencies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Human Granulocytic Ehrlichiosis Market is poised for moderate but sustained expansion, likely to post a CAGR of 6.4 %, with an estimated value of around USD 354 mi... Read More

Published Date: JAN-2026 | No Of Pages:156 | $ 4485

Proliferative Diabetic Retinopathy Market By Treatment Modality (Anti-VEGF Therapies, Laser Photocoagulation, Vitrectomy & Surgical Interventions, Steroid Injections); By Diagnostic Modality (Fundus Photography, Optical Coherence Tomography, Fluorescein Angiography, AI-Assisted Retinal Screening & Other Imaging Technologies); By End User (Ophthalmology & Retina Clinics, Hospitals, Ambulatory Surgical Centers, Diagnostic Imaging Centers, Primary Care & Community Screening Centers); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Segment Revenue Estimation, Forecast, 2026–2032

Proliferative Diabetic Retinopathy Market: Screening Gaps and Recurring Retinal Therapy Shift Revenue Beyond One-Time Laser

The Global Proliferative Diabetic Retinopathy Market is projected to grow from USD 3.27 billion in 2025 to USD 5.64 billion by 2032, expanding a... Read More

Published Date: JUL-2026 | No Of Pages:151 | $ 4485

X-linked Adrenal Hypoplasia Congenita (AHC) Market By Treatment Type (Hormone Replacement Therapy, Gene Therapy, Supportive Therapies); By Diagnostic Approach (Genetic Testing, Endocrine Function Testing); By End-User (Hospitals, Specialty Clinics, Homecare Providers, Research Institutions, Genetic Counseling Services); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global X-Linked Adrenal Hypoplasia Congenita (AHC) Market will witness a robust CAGR of 7.5%, valued at USD 500 million in 2024... Read More

Published Date: JAN-2026 | No Of Pages:160 | $ 4485

Atelosteogenesis Treatment Market By Treatment Type (Gene Therapy, Bone Regeneration Therapy, Supportive Treatments); By Therapeutic Approach (Monotherapies, Combination Therapies); By End User (Children’s Hospitals, General Hospitals, Specialty Clinics, Research Institutes); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Atelosteogenesis Treatment Market is poised for significant growth over the next decade. Atelosteogenesis, a rare genetic disorder characterized by abnormal bone deve... Read More

Published Date: JAN-2026 | No Of Pages:152 | $ 4485

Mycobacterium Abscessus Treatment Market By Drug Class (Macrolides, Aminoglycosides, Beta-lactams, Tetracyclines, Oxazolidinones, Pipeline Agents); By Route of Administration (Oral, Intravenous, Inhalation); By Patient Population (Cystic Fibrosis, Non-CF Bronchiectasis, Immunocompromised/Transplant); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Mycobacterium Abscessus Treatment Market valued at USD 370 million in 2024 and projected to reach USD 545 million by 2030 at 6.5% CAGR, driven by ... Read More

Published Date: JAN-2026 | No Of Pages:174 | $ 4485

Congenital Anosmia Treatment Market by Treatment Type (Gene Therapy, Stem Cell Therapy, Neurostimulation Devices, Pharmacological Treatments); By End User (Specialized Clinics, Hospitals, Research Institutions, Homecare Providers); By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa); Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Congenital Anosmia Treatment Market is expected to experience robust growth from 2024 to 2030, driven by advancements in medical technology and increasing awareness of rare diseases. Congenital anosmia, a rare co... Read More

Published Date: JAN-2026 | No Of Pages:189 | $ 4485

Hydroxylase Deficiency Market By Disorder Type (21-hydroxylase deficiency, 11-beta-hydroxylase deficiency, prolyl hydroxylase deficiency, dopamine beta-hydroxylase deficiency, others); By Treatment Modality (Hormone Replacement Therapy, Gene Therapy, Enzyme Replacement, Small Molecule Modulators); By End User (Tertiary Hospitals, Pediatric Clinics, Specialty Pharmacies, Regional/Community Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hydroxylase Deficiency Market is expected to see steady growth through 2030, driven by expanding newborn screening, earlier diagnosis, and steady investment in orphan drug research. According to St... Read More

Published Date: JAN-2026 | No Of Pages:176 | $ 4485

Autoimmune Gastrointestinal Dysmotility Market By Treatment Type (Immunotherapy, Motility Agents, Symptom Management, Nutritional Support, Emerging Biologics); By Diagnostic Approach (Antibody Testing, GI Motility Testing, Imaging, Autonomic Testing, Molecular Diagnostics); By End User (Tertiary Care Hospitals, Specialty Clinics, Diagnostic Labs, Academic & Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Autoimmune Gastrointestinal Dysmotility Market is projected to grow at a CAGR of 8.9%, with an estimated value of USD 512.6 million in 2024 and forecasted to reach Read More

Published Date: JAN-2026 | No Of Pages:159 | $ 4485

Hydatidiform Mole Market By Diagnostic Method (Ultrasound Imaging, Blood Tests, Genetic Testing); By Treatment Option (Surgical Evacuation, Chemotherapy, Observation and Monitoring); By End User (Hospitals, Fertility Clinics, Diagnostic Imaging Centers, Research Institutes); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hydatidiform Mole Market is poised to experience steady growth, with a robust CAGR of 5.6% expected between 2024 and 2030. Valued at approximately Read More

Published Date: JAN-2026 | No Of Pages:167 | $ 4485

Anthrax Treatment Market By Product Type (Antibiotics, Vaccines, Monoclonal Antibodies, Other Therapies); By Treatment Application (Human Treatment, Veterinary Treatment); By End User (Hospitals, Veterinary Clinics, Government and Military, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Anthrax Treatment Market valued at USD 1.2 billion in 2024 and projected to reach USD 2.1 billion by 2030 at 7.5% CAGR, driven by biodefense progr... Read More

Published Date: JAN-2026 | No Of Pages:170 | $ 4485

Leber Congenital Amaurosis Market By Therapy Type (Gene Therapy, Pharmacological Therapy, Retinal Prosthetics); By Genetic Subtype (RPE65 Mutations, CEP290 Mutations, Other Rare Mutations); By End User (Specialty Ophthalmology Clinics, Hospitals and Eye Centers, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Leber Congenital Amaurosis Market valued at USD 1.2 billion in 2024 and projected to reach USD 1.7 billion by 2030 at 6.5% CAGR, driven by gene th... Read More

Published Date: JAN-2026 | No Of Pages:151 | $ 4485

Ovarian Cyst Management Market By Product and Service (Diagnostic Imaging [Ultrasound, Magnetic Resonance Imaging, Computed Tomography], Laboratory and Risk-Assessment Tests, Pharmaceuticals [Hormonal Contraceptives, Analgesics and Supportive Medicines], Surgical Products and Services [Laparoscopic Instruments and Consumables, Open Surgical Instruments and Consumables], Monitoring and Follow-Up Services); By Application (Initial Diagnosis and Risk Classification, Watchful Waiting and Repeat Monitoring, Hormonal and Symptomatic Management, Laparoscopic Cystectomy, Laparotomy, Oophorectomy, Aspiration and Sclerotherapy, Emergency Management of Torsion and Rupture, Pregnancy-Associated Ovarian Cyst Management, Fetal Ovarian Cyst Management); By End User (Hospitals, Gynecology Clinics, Diagnostic Imaging Centres, Clinical and Reference Laboratories, Ambulatory Surgical Centres, Fertility and Reproductive Medicine Centres, Maternal-Fetal Medicine Centres); By Cyst Type (Functional Cysts, Simple Cysts, Dermoid Cysts, Endometriomas, Cystadenomas, Complex and Indeterminate Cysts, Pregnancy-Associated Cysts, Fetal Ovarian Cysts); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Ovarian Cyst Management Market: Ultrasound Triage and Selective Surgery Shape Revenue Growth

The Global Ovarian Cyst Management Market was valued at USD 3.37 billion in 2025 and is projected to reach USD 4.87 ... Read More

Published Date: JUL-2026 | No Of Pages:180 | $ 4485

Anaplasmosis Treatment Market By Treatment Type (Antibiotics, Supportive Therapies, Experimental / Pipeline Therapies); By Route of Administration (Oral, Intravenous); By End User (Hospitals, Clinics and Outpatient Centers, Veterinary Clinics); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Anaplasmosis Treatment Market: Rising Case Detection Expands Testing and Hospital Revenue While Generic Doxycycline Limits Drug Pricing

 

The Global Anaplasmosis Treatment Market is estimated to reach USD 8.05 billion in 2025Read More

Published Date: JUL-2026 | No Of Pages:193 | $ 4485

Psychedelic Mushroom Market By Product Form (Dried Psychedelic Mushrooms, Fresh Psychedelic Mushrooms, Standardized Mushroom Extracts, Naturally Derived Psilocybin Capsules, Cultivation Kits and Spores, Other Processed Mushroom Products); By Dosage Format (Microdose Formulations, Low-Dose Capsules, Standard Therapeutic Doses, High-Dose Clinical Protocols, Variable-Potency Whole-Mushroom Products); By Application (Treatment-Resistant Depression, Major Depressive Disorder, Anxiety and Cancer-Related Distress, Post-Traumatic Stress Disorder, Substance-Use Disorders, Wellness and Microdosing, Clinical Research, Other Applications); By End User (Hospitals, Specialty Psychiatric Clinics, Authorized Prescribers, Academic and Research Institutions, Contract Research Organizations, Regulated Psychedelic Access Centers, Individual Consumers); By Distribution and Access Channel (Hospital and Clinic Procurement, Licensed Pharmacies, Direct-to-Research Supply, Compassionate-Use Programs, Regulated Access Services, Online and Gray-Market Channels); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Psychedelic Mushroom Market: Pharmaceutical Consolidation, Gray-Market Pricing, and Dose Standardization Redefine Commercial Growth

The Global Psychedelic Mushroom Market was valued at approximately USD 6.98 billion in 2025 and is projected to reach USD 16.02 billion ... Read More

Published Date: JAN-2026 | No Of Pages:188 | $ 4485

Germ Cell Tumor Market By Tumor Type (Testicular Germ Cell Tumors, Ovarian Germ Cell Tumors, Extragonadal Germ Cell Tumors); By Treatment Modality (Chemotherapy, Surgery, Stem Cell Transplantation, Targeted & Immunotherapy); By End User (Specialized Cancer Centers, General Hospitals, Fertility Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Germ Cell Tumor GCT Market growing at 6.5% CAGR, expanding from USD 2.8 billion in 2024 to USD 4.1 billion by 2030, driven by market growth, indus... Read More

Published Date: JAN-2026 | No Of Pages:173 | $ 4485

Palmoplantar Pustulosis (PPP) Market By Treatment Type (Topical Therapies, Systemic Non-Biologics, Biologics, Phototherapy); By Route of Administration (Topical, Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Palmoplantar Pustulosis Market is projected to expand steadily between 2024 and 2030, with an estimated value of USD 780 million in 2024 ... Read More

Published Date: JAN-2026 | No Of Pages:196 | $ 4485

Geographic Atrophy Market By Therapy Type (Complement Inhibitors, Gene Therapy & Regenerative Approaches, Small Molecules & Others); By Route of Administration (Intravitreal Injections, Oral & Topical Routes, Sustained-Release Implants); By End User (Specialty Ophthalmology Clinics, Hospitals & Academic Centers, Ambulatory Surgical Centers, Community Eye Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Geographic Atrophy Market growing at 8.5% CAGR, expanding from USD 2.3 billion in 2024 to USD 4.0 billion by 2030, driven by market growth, indust... Read More

Published Date: JAN-2026 | No Of Pages:175 | $ 4485

Gynecomastia Treatment Market By Treatment Type (Surgical, Non-Surgical); By End User (Hospitals, Aesthetic Clinics, Ambulatory Surgical Centers, Endocrinology Clinics); By Age Group (Adolescents, Adults, Middle-Aged & Older); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gynecomastia Treatment Market valued at USD 1.72 billion in 2024 and projected to reach USD 2.56 billion by 2030 at 6.8% CAGR, supported by indust... Read More

Published Date: JAN-2026 | No Of Pages:195 | $ 4485

JAK3 Inhibitor Market By Product Type (Selective JAK3 Inhibitors, Pan-JAK Inhibitors with JAK3 Activity); By Therapeutic Indication (Rheumatoid Arthritis, Psoriasis, Ulcerative Colitis, Hematologic Malignancies, Others); By Route of Administration (Oral, Parenteral); By End User (Hospitals, Specialty Clinics, Retail Pharmacies & Outpatient Centers, Academic & Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

JAK3 Inhibitor Market: Selective Immune Modulation Moves from Scientific Rationale to Commercial Validation

The Global JAK3 Inhibitor Market was valued at USD 2.51 billion in 2025 and is projected to reach USD 4.62 billion by 2032, expanding at a CAGR of 9.1% during 2... Read More

Published Date: AUG-2026 | No Of Pages:168 | $ 4485

Carboxy Therapy Market By Product Type (Professional Devices, At-Home Kits); By Application (Aesthetic, Medical/Therapeutic); By End User (Aesthetic Clinics & Dermatology Centers, Hospitals & Medical Centers, Wellness & Spa Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Carboxy Therapy Market growing at 12.3% CAGR, expanding from USD 1.2 billion in 2024 to USD 2.3 billion by 2030, driven by market growth, industry... Read More

Published Date: JAN-2026 | No Of Pages:197 | $ 4485

Endothelial Dysfunction Market By Product Type (Diagnostics, Therapeutics, Digital Health Solutions); By Application (Cardiovascular Risk, Metabolic Syndrome, Chronic Kidney Disease, Others); By End User (Hospitals, Diagnostic Laboratories, Specialty Clinics, Primary Care Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Endothelial Dysfunction Market growing at 7.4% CAGR, expanding from $2.8 billion in 2024 to $4.7 billion by 2030, driven by market growth, industr... Read More

Published Date: JAN-2026 | No Of Pages:169 | $ 4485

Low-Grade Glioma Market By Treatment Type (Surgery, Chemotherapy, Targeted Therapy, Radiotherapy, Surveillance); By Tumor Subtype (Astrocytoma, Oligodendroglioma, Mixed Glioma); By End User (Academic Centers, Community Hospitals, Diagnostic Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Low-Grade Glioma Market growing at 5.8% CAGR, expanding from $1.4 billion in 2024 to $2.0 billion by 2030, driven by market growth, industry analy... Read More

Published Date: JAN-2026 | No Of Pages:178 | $ 4485

Gastroesophageal Junction Adenocarcinoma Market By Therapy Type (Targeted Therapy, Immunotherapy, Chemotherapy, Surgical Intervention); By Diagnostic Approach (Imaging, Histopathology, Molecular Diagnostics); By End User (Hospitals, Oncology Clinics, Reference Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gastroesophageal Junction Adenocarcinoma Market is set to experience notable growth between 2024 and 2030, the market is valued at an estimated $2.2 billion in 2024 and is projected to rea... Read More

Published Date: JAN-2026 | No Of Pages:191 | $ 4485

Whim Syndrome Management Market By Drug Type (G-CSFs, Immunoglobulin Therapy, CXCR4 Antagonists); By Route of Administration (Subcutaneous, Intravenous, Oral); By End User (Hospitals, Specialty Clinics, Pediatric Tertiary Centers, Home Care); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Whim Syndrome Management Market is expected to advance at a steady CAGR of 10.1%, valued at around $54 million in 2024 and projected to reach nearly $96 million by... Read More

Published Date: JAN-2026 | No Of Pages:184 | $ 4485

Pollen Allergy Market By Treatment Type (Pharmacotherapy, Immunotherapy [SCIT, SLIT], Biologic Therapies); By Route of Administration (Oral, Nasal, Injectable); By Distribution Channel (Hospital & Allergy Clinics, Retail Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pollen Allergy Market is projected to grow at a steady CAGR of 5.8%, valued at USD 8.9 billion in 2024, and anticipated to reach USD 12.5 billion by 2030,... Read More

Published Date: JAN-2026 | No Of Pages:168 | $ 4485

Pemphigus Vulgaris Market By Treatment Type (Corticosteroids, Immunosuppressants, Monoclonal Antibodies, Small Molecules); By Route of Administration (Oral, Intravenous, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pemphigus Vulgaris Market is forecast to grow at a CAGR of 6.5%, increasing from USD 708 million in 2024 to USD 1.04 billion by 2030, driven by bi... Read More

Published Date: JAN-2026 | No Of Pages:198 | $ 4485

Undescended Testicle Market By Treatment Type (Surgery, Hormonal Therapy); By Age Group (Infants, Toddlers, Older Children); By End User (Pediatric Hospitals, General Hospitals, Specialty Clinics, Outpatient Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Undescended Testicle Market is expected to post a steady CAGR of 6.8% , with an estimated market value of USD 460 million in 2024 and a p... Read More

Published Date: JAN-2026 | No Of Pages:195 | $ 4485

Spina Bifida In-Utero Market By Procedure Type (Open Fetal Surgery, Minimally Invasive/Fetoscopic Repair); By Application (Myelomeningocele Correction, Other Neural Tube Defects); By End User (Academic Hospitals, Children’s Hospitals, Regional Perinatal Centers, General Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Spina Bifida In-Utero Market will expand at a consistent CAGR of 8.6%, moving from USD 397 million in 2024 to USD 650 million by 2030, propelled by Read More

Published Date: JAN-2026 | No Of Pages:152 | $ 4485

Sialorrhea Treatment Market By Treatment Type (Oral Anticholinergic Medicines, Botulinum Toxin Injections, Surgical and Interventional Procedures, Radiotherapy); By Disease Indication (Parkinson’s Disease, Cerebral Palsy, Amyotrophic Lateral Sclerosis, Stroke and Traumatic Brain Injury, Clozapine-Induced Sialorrhea, Neurodevelopmental Disorders); By Patient Group (Pediatric Patients, Adult Patients); By End User (Hospitals, Neurology Clinics, Pediatric Specialty Clinics, Rehabilitation Centers, ENT Clinics, Long-Term Care and Home-Care Settings); By Region, Segment Revenue Estimation, Forecast, 2026–2032

Sialorrhea Treatment Market Gains from Neurologic Disease Burden, Botulinum Toxin Access, and Pediatric Drooling Control

The Global Sialorrhea Treatment Market was valued at USD 734 million in 2025 and is projected to reach USD 1.08 billion by 2032, growing at a CAGR ... Read More

Published Date: JUL-2026 | No Of Pages:192 | $ 4485

Ophthalmoplegia Market By Type (External Ophthalmoplegia, Internal Ophthalmoplegia, Complete Ophthalmoplegia); By Cause (Stroke, Diabetes, Autoimmune Disorders, Mitochondrial Disease, Tumors); By Treatment (Pharmacological, Surgical, Botulinum Toxin, Rehabilitation); By End User (Tertiary Hospitals, Specialty Clinics, Rehabilitation Centers, Surgical Eye Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ophthalmoplegia Market is expected to grow at a steady CAGR of 5.8%, valued at USD 1.2 billion in 2024, and projected to surpass USD 1.7 billion by 2030, ... Read More

Published Date: JAN-2026 | No Of Pages:151 | $ 4485

Muckle Wells Syndrome Market By Therapy Type (IL-1 Inhibitors, Corticosteroids & NSAIDs, Emerging Agents); By Route of Administration (Injectable, Oral); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Muckle Wells Syndrome Market is anticipated to see steady but specialized growth over the forecast period, with an CAGR of 6.5% . The mar... Read More

Published Date: JAN-2026 | No Of Pages:159 | $ 4485

Hyperhidrosis Treatment Market By Treatment Type (Botox Injections, Iontophoresis, Microwave Therapy, Surgical Procedures, Topical Treatments); By End User (Dermatology Clinics, Hospitals, Outpatient Clinics, Home Care); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hyperhidrosis Treatment Market is expected to expand at a CAGR of 7.5% from 2024 to 2030, increasing from $4.1 billion in 2024 to $6.8 Billion in 2030, fu... Read More

Published Date: JAN-2026 | No Of Pages:181 | $ 4485

Human Osteoblasts Market by Type (Primary Osteoblasts, Induced Osteoblasts, Stem Cell-Derived Osteoblasts); By Application (Bone Regeneration, Osteoporosis Treatment, Fracture Healing, Bone Cancer Research); By End-User (Hospitals, Research Institutes, Biotech Companies, Imaging Centers, ASCs); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Human Osteoblasts Market is projected to grow from an estimated USD 3.5 billion in 2024 to USD 6.5 billion by 2030, with a CAGR of 10% during this period, driven... Read More

Published Date: JAN-2026 | No Of Pages:176 | $ 4485

Homozygous Familial Hypercholesterolemia Market By Drug Class (Statins, PCSK9 Inhibitors, Lomitapide, Gene Therapy, RNA-based Therapeutics); By Route of Administration (Oral, Subcutaneous, Intravenous); By Patient Age Group (Pediatric, Adult); By End User (Specialty Lipid Clinics, Academic Hospitals, General Hospitals, Payers/Managed Care); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Homozygous Familial Hypercholesterolemia Market is set to witness CAGR of 11.3%, growing from $1.14 billion in 2024 to $2.15 billion by 2030, driven by Read More

Published Date: JAN-2026 | No Of Pages:169 | $ 4485

Histoplasmosis Treatment Market By Drug Type (Azoles, Polyenes, Adjunctive Therapies); By Route of Administration (Oral, Intravenous); By Patient Group (Immunocompromised, Immunocompetent); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Histoplasmosis Treatment Market will grow at a CAGR of 6.3%, with a valuation of USD 1.6 billion in 2024 and expected to hit USD 2.3 billion by 2030, supp... Read More

Published Date: JAN-2026 | No Of Pages:194 | $ 4485

Group B Streptococcus Infection Treatment Market By Drug Class (Beta-lactam Antibiotics, Clindamycin & Alternatives, Pipeline Therapies); By Route of Administration (Intravenous, Oral); By End User (Hospitals, Maternity Clinics & Birthing Centers, Diagnostic Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Group B Streptococcus (GBS) Infection Treatment Market is set to witness a steady CAGR of 5.4% , valued... Read More

Published Date: JAN-2026 | No Of Pages:186 | $ 4485

Gingival Recession Market By Product Type (Soft Tissue Grafts, Regenerative Biomaterials, Dental Membranes, Growth Factors); By Treatment Approach (Surgical Flap Procedures, Connective Tissue Grafts, Guided Tissue Regeneration); By End User (Private Clinics, Hospitals, Academic Institutions, Specialty Periodontal Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gingival Recession Market is expected to grow steadily, with an valuation of 1.9 billion USD in 2024 and projected to reach 2.8 billion USD by 2030 . This reflects a Read More

Published Date: JAN-2026 | No Of Pages:152 | $ 4485

Familial Adenomatous Polyposis Treatment Market By Treatment Type (Pharmacologic Therapy, Surgical Intervention, Gene Therapy); By End User (Hospitals, Specialty Clinics, Research Centers); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Familial Adenomatous Polyposis Treatment Market is poised to grow at a robust CAGR of 8.2%, valued at USD 1.3 billion in 2024 and projected to reach USD 2.1 billio... Read More

Published Date: JAN-2026 | No Of Pages:150 | $ 4485

Recurrent Pericarditis Market by Treatment Type (Biologic Therapies, NSAIDs, Colchicine, Corticosteroids, Surgical Interventions); By End User (Hospitals, Specialty Clinics, Diagnostic Imaging Centers, Ambulatory Surgical Centers); By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa); Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Recurrent Pericarditis Market will expand steadily at a CAGR of 6.5%, reaching $2.1 billion by 2030 from $1.2 billion in 2024, supported by cardia... Read More

Published Date: JAN-2026 | No Of Pages:192 | $ 4485

Postoperative Pain Management Market By Product Type (Non-Opioid Analgesics, Opioid Analgesics, Local Anesthetics, Adjuvant Therapies, Devices, Digital Solutions); By Route of Administration (Oral, Intravenous, Regional, Transdermal, Others); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Home Healthcare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Postoperative Pain Management Market is set to expand at a CAGR of 6.1%, with a market value of USD 13.2 billion in 2024, projected to reach USD 18.8 billion by 20... Read More

Published Date: JAN-2026 | No Of Pages:173 | $ 4485

Bladder Cancer Therapeutics Market By Therapy Type (Chemotherapy, Immunotherapy, Targeted Therapy, Intravesical Therapy, Combination Therapy); By Disease Stage (Non-Muscle-Invasive Bladder Cancer, Muscle-Invasive Bladder Cancer, Metastatic Bladder Cancer); By Route of Administration (Intravenous, Oral, Intravesical); By End User (Hospitals and Cancer Centers, Specialty Urology Clinics, Ambulatory Surgical Centers, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bladder Cancer Therapeutics Market will witness steady expansion at a CAGR of 7.6%, valued at USD 4.2 billion in 2024 and projected to reach USD 6.52 billion by 20... Read More

Published Date: JAN-2026 | No Of Pages:151 | $ 4485

Giant Cell Arteritis Market By Therapy Type (Corticosteroids, Biologics, Supportive Therapies); By Route of Administration (Oral, Injectable [Subcutaneous, Intravenous]); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Giant Cell Arteritis (GCA) Market will witness steady expansion, valued at USD 1.3 billion in 2024 and projected to reach USD 2.1 billion by 2030, growing at a CAG... Read More

Published Date: JAN-2026 | No Of Pages:166 | $ 4485

Giant Papillary Conjunctivitis Market By Treatment Type (Antihistamines & Mast Cell Stabilizers, Corticosteroids, Immunomodulators, Lubricants & Supportive Care); By Route of Administration (Topical Eye Drops, Ophthalmic Inserts, Systemic Therapy); By Distribution Channel (Retail Pharmacies & Drug Stores, Online Pharmacies, Hospital & Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2025–2030.

Introduction And Strategic Context

The Global Giant Papillary Conjunctivitis (GPC) Market is projected to grow at a CAGR of 6.5% between 2024 and 2030, climbing from an estimated value of USD 1.26 billion in 2024 to a... Read More

Published Date: JAN-2026 | No Of Pages:197 | $ 4485

Giant Axonal Neuropathy Market By Treatment Type (Gene Therapy, Antisense Oligonucleotides, Supportive & Symptomatic Care); By Route of Administration (Intrathecal, Intravenous, Oral & Others); By End User (Academic & Research Hospitals, Specialty Neurology Clinics, Pediatric Rehabilitation Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Giant Axonal Neuropathy (GAN) Market is projected to grow at a CAGR of 19.8% between 2024 and 2030, with an estimated market size of USD 78.2 million in 2024 and reaching ... Read More

Published Date: JAN-2026 | No Of Pages:187 | $ 4485

Gestational Diabetes Market By Treatment Type (Insulin Therapy, Oral Hypoglycemic Agents, Lifestyle & Nutritional Management); By Diagnostic Approach (OGTT & GCT, HbA1c Testing, Continuous Glucose Monitoring); By End User (Hospitals & Maternity Clinics, Diagnostic Laboratories, Digital Health Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gestational Diabetes Market is projected to grow at a steady CAGR of 6.7%, valued at USD 2.8 billion in 2024 and anticipated to reach USD 4.1 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:159 | $ 4485

Frontotemporal Dementia Market By Offering (Diagnostics, Therapeutics, Supportive Care & Long-Term Care Services); By Disease Type (Behavioral-Variant Frontotemporal Dementia, Primary Progressive Aphasia, FTD With Motor Neuron Disease/Movement Disorders, Other FTD Spectrum Disorders); By Diagnostic Modality (Neuroimaging, Genetic Testing & Counseling, Neuropsychological & Language Assessment, CSF/PET/Biomarker Testing); By Genetic Profile (Sporadic FTD, GRN Mutation FTD, C9orf72-Associated FTD, MAPT-Associated FTD); By Treatment Approach (Symptomatic Management & Multidisciplinary Supportive Care, Progranulin Replacement Therapies, GRN Gene Therapy, Other Disease-Modifying Pipeline Therapies); By End User (Hospitals & Memory Clinics, Specialty Neurology Centers, Genetic Testing Laboratories & Counseling Centers, Research Institutes & Clinical Trial Sites, Home Care & Long-Term Support Providers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Frontotemporal Dementia Market: Genetic Diagnosis, Supportive-Care Spending and Progranulin Programs Redefine Commercial Opportunity

The Global Frontotemporal Dementia Market is valued at USD 3.92 billion in 2025 and is projected to reach USD 7.35 billion by 2032, exp... Read More

Published Date: JUL-2026 | No Of Pages:192 | $ 4485

Excessive Daytime Sleepiness Market By Drug Class (Stimulants, Wakefulness-Promoting Agents, Non-Stimulant Therapies, Digital Therapeutics); By Underlying Condition (Obstructive Sleep Apnea, Narcolepsy, Idiopathic Hypersomnia, Shift Work Sleep Disorder); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online/Telehealth Channels); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Excessive Daytime Sleepiness Market is anticipated to expand at a CAGR of 8.1%, estimated at $4.3 billion in 2024 and projected to reach $6.8 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:199 | $ 4485

Erosive Hand Osteoarthritis Market By Treatment Type (Pharmacological Treatment, Surgical Treatment, Non-Pharmacological Treatment); By End User (Hospitals, Specialty Clinics, Outpatient Care Centers); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Erosive Hand Osteoarthritis Market is poised to grow at a CAGR of 6.3% , reaching an estimated value of USD 1.12 billion by 2030 , up from USD 780... Read More

Published Date: JAN-2026 | No Of Pages:158 | $ 4485

Epithelioid Sarcoma Treatment Market By Treatment Modality (Surgery and Reconstruction, Chemotherapy, Radiation Therapy, Targeted/Precision Therapy, Immunotherapy and Clinical Trial-Based Therapy, Supportive Care and Surveillance); By Disease Stage (Localized Resectable Disease, Locally Advanced/Unresectable Disease, Recurrent Disease, Metastatic Disease); By Care Setting/End User (Specialist Sarcoma Centers and Tertiary Cancer Hospitals, General Hospitals and Oncology Clinics, Ambulatory Surgical Centers, Research Institutes and Clinical Trial Sites); By Geography, Segment Revenue Estimation and Forecast, 2026–2032

Epithelioid Sarcoma Treatment Market: Tazverik Withdrawal, Surgery-Led Care, and Biomarker Trials Reset Competition

The Global Epithelioid Sarcoma Treatment Market was valued at USD 1.54 billion in 2025 and is projected to reach USD 3.26 billion by 2032, growing at a ... Read More

Published Date: JUL-2026 | No Of Pages:150 | $ 4485

Emphysema Market By Treatment Type (Inhaled Medications, Biologics, Surgical & Device-Based Interventions, Pulmonary Rehabilitation & Oxygen Therapy); By Route of Administration (Inhalation, Oral, Injectable/Biologic); By End User (Hospitals, Retail Pharmacies, Homecare Providers, Payers); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Emphysema Market is projected to grow steadily between 2024 and 2030, valued at USD 6.8 billion in 2024 and forecasted to reach USD 9.7 billion by 2030 , ... Read More

Published Date: JAN-2026 | No Of Pages:166 | $ 4485

Ebola Fever Therapeutics Market By Product Type (Monoclonal Antibody Therapies, Antiviral Agents, RNA-Based Therapeutics, Supportive Therapies & Immunomodulators); By Route of Administration (Intravenous, Oral, Intramuscular/Subcutaneous); By Distribution Channel (Government & Public Health Procurement, NGOs & Humanitarian Agencies, Hospital Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2025–2030.

Introduction And Strategic Context

The Global Ebola Fever Therapeutics Market is projected to expand steadily at a CAGR of 6.9% , growing from an estimated USD 1.02 billion in... Read More

Published Date: JAN-2026 | No Of Pages:165 | $ 4485

Diverticulitis Market By Treatment Type (Medical, Surgical); By Product Type (Pharmaceuticals, Nutritional Therapies, Surgical Devices, Digital Monitoring Tools); By Disease Type (Uncomplicated, Complicated); By End User (Hospitals, Gastroenterology Clinics, Ambulatory Surgical Centers, Imaging Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Diverticulitis Market expanding from USD 4.1 billion in 2024 to USD 6.0 billion by 2030 at a CAGR of 6.5%, reflecting market growth, Read More

Published Date: JAN-2026 | No Of Pages:158 | $ 4485

Diarrhea Therapeutics Market By Drug Class (Oral Rehydration Salts, Anti-Motility Agents, Antibiotics, Probiotics, Zinc Supplements); By Route of Administration (Oral, Intravenous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Diarrhea Therapeutics Market will witness a steady CAGR of 5.8% , valued at USD 9.6 billion in 2024 and expected to reac... Read More

Published Date: JAN-2026 | No Of Pages:199 | $ 4485

Congenital Adrenal Hyperplasia Treatment Market By Drug Type (Glucocorticoids, Mineralocorticoids, Steroidogenesis Inhibitors, CRF1 Receptor Antagonists); By Route of Administration (Oral, Injectable, Transdermal); By Age Group (Pediatric, Adolescent, Adult); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Congenital Adrenal Hyperplasia (CAH) Treatment Market will register growth at a CAGR of 6.8%, expanding from USD 472 million in 2024 to USD 703 million by 2030Read More

Published Date: JAN-2026 | No Of Pages:185 | $ 4485

Clinically Isolated Syndrome Market By Drug Class (Injectables, Oral Therapies, Monoclonal Antibodies); By Diagnostic Tool (MRI, CSF Analysis, Optical Coherence Tomography, Evoked Potentials); By Patient Type (Adults, Pediatric Onset, High-Risk Patients); By End User (Neurology Clinics, Imaging Centers, Hospitals, Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Clinically Isolated Syndrome (CIS) Market is projected to grow at a steady CAGR of 6.5% , reaching an estimated value of $2.6 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:155 | $ 4485

Clear Cell Ovarian Cancer Market By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Surgical Intervention); By Disease Stage (Stage I–II, Stage III–IV); By End User (Academic & Research Hospitals, Cancer Specialty Centers, General Hospitals, Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Clear Cell Ovarian Cancer Market is projected to expand at a CAGR of 6.8%, reaching approximately USD 1.9 billion by 2030, up from an estimated USD 1.3 billion in ... Read More

Published Date: JAN-2026 | No Of Pages:164 | $ 4485

Chronic Traumatic Encephalopathy Market By Diagnostic Type (Neuroimaging, Blood Biomarkers, Neurocognitive Tools); By Intervention Type (Symptom Management Drugs, Neuroprotective Therapies, Behavioral and Cognitive Therapy); By End User (Neurology Clinics, Sports Medicine Institutions, Veteran Health Systems, Academic Research Institutes); By Geography, Segment Revenue Estimation and Forecast, 2026–2032

Chronic Traumatic Encephalopathy Market: Living-Diagnosis Bottleneck Shifts Revenue Toward Biomarkers, Exposure Reduction, and Long-Term Neurological Care

The Global Chronic Traumatic Encephalopathy Market is projected to expand at a CAGR of 9.1%, rising from USD 1.20... Read More

Published Date: JUL-2026 | No Of Pages:192 | $ 4485

Chronic Myelomonocytic Leukemia Market By Treatment Type (Hypomethylating Agents, Targeted Therapies, Stem Cell Transplantation, Supportive Care); By Route of Administration (Injectable, Oral); By End User (Academic Medical Centers, Community Oncology Clinics, Transplant Centers, Specialized Hematology Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Myelomonocytic Leukemia (CMML) Market was valued at approximately USD 720 Million in 2024 and is projected to surpass USD 1.1 Billion by 2030, expanding at aRead More

Published Date: JAN-2026 | No Of Pages:180 | $ 4485

Chronic Idiopathic Urticaria Treatment Market By Drug Class (Antihistamines, Monoclonal Antibodies, Leukotriene Receptor Antagonists, Immunosuppressants); By Route of Administration (Oral, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Idiopathic Urticaria Treatment Market is anticipated to grow from USD 4.8 billion in 2024 to around USD 7.6 billion by 2030, achieving a CAGR of 7.9% (2024... Read More

Published Date: JAN-2026 | No Of Pages:187 | $ 4485

Cervical Intraepithelial Neoplasia Market By CIN Grade (CIN I, CIN II, CIN III); By Diagnostic Method (Pap Smear, HPV Testing, Colposcopy, Biomarker Triage); By Treatment (Cryotherapy, LEEP, Cold Knife Conization, Immunotherapy); By End User (Hospitals, Specialty Clinics, Diagnostic Labs, Community Health Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cervical Intraepithelial Neoplasia (CIN) Market will witness a steady CAGR of 6.8%, valued at USD 1.32 billion in 2024, and projected to ... Read More

Published Date: JAN-2026 | No Of Pages:185 | $ 4485

Cerebrotendinous Xanthomatosis Market By Treatment Type (Chenodeoxycholic Acid, Adjunctive Therapies, Pipeline/Investigational Drugs); By Route of Administration (Oral, Future-IV/Subcutaneous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online/Compounding Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cerebrotendinous Xanthomatosis Market is projected to grow at a CAGR of 6.7% , with a market value of USD 223.0<... Read More

Published Date: JAN-2026 | No Of Pages:188 | $ 4485

Cardiovascular Calcification Market By Product Type (Imaging Systems, Atherectomy Devices, Drug-Eluting Stents, Transcatheter Heart Valves); By Application (Coronary Artery Disease, Aortic Valve Stenosis, Peripheral Artery Disease, CKD-Related Vascular Calcification); By End User (Hospitals, Ambulatory Surgical Centers, Cardiac Clinics, Dialysis & Nephrology Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cardiovascular Calcification Market is projected to rise at a CAGR of 6.5%, valued at USD 2.9 billion in 2024 and expected to reach USD 4.3 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:190 | $ 4485

Cannabis Use Disorder Market By Treatment Type (Pharmacological, Non-Pharmacological); By Delivery Channel (Outpatient Clinics, Digital Therapeutics, Primary Care, University Programs); By Patient Demographics (Age Group, Gender); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cannabis Use Disorder Market is projected to reach $3.1 billion in 2030 , up from an estimated $1.8 billion in 2024 , growing at a CAGR of 9.4% during the... Read More

Published Date: JAN-2026 | No Of Pages:189 | $ 4485

Bronchiolitis Obliterans Syndrome Market By Treatment Type (Immunosuppressants, Corticosteroids, Macrolides, Antifibrotics); By Application (Lung Transplant-Associated BOS, HSCT-Associated BOS); By Route of Administration (Oral, Inhalation, Intravenous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bronchiolitis Obliterans Syndrome Market will grow at a CAGR of 6.5% , valued at nearly USD 1.42 billion in 2024 and projected to reach around USD 2.08 billion by ... Read More

Published Date: JAN-2026 | No Of Pages:178 | $ 4485

Bronchial Spasm Market By Drug Type (Short-acting β2-Agonists, Long-acting Bronchodilators, Anticholinergics, Leukotriene Receptor Antagonists); By Route of Administration (Inhaled [MDI, DPI], Nebulized, Oral, Others); By End User (Hospitals, Specialty Clinics, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bronchial Spasm Market is projected to grow at a steady CAGR of 6.4% , increasing from a market value of USD 1.42 billion in 2024 to USD 2.07 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:163 | $ 4485

Blastomycosis Treatment Market By Treatment Type (Antifungal Drugs, Surgical Intervention); By End-User (Hospitals, Outpatient Clinics, Diagnostic Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Blastomycosis Treatment Market is valued at USD 3.4 billion in 2024 and is expected to reach USD 5.7 billion by 2030, growing at a Read More

Published Date: JAN-2026 | No Of Pages:195 | $ 4485

BK Virus Infection Market By Product Type (Diagnostic Tests, Therapeutic Solutions); By Application (Organ Transplants, Immunocompromised Patients); By End-User (Hospitals & Transplant Centers, Diagnostic Laboratories, Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global BK Virus Infection Market is valued at approximately USD 500 million in 2024, projected to reach USD 750 million by 2030, progressing at a CAGR of 7% from 2024 to ... Read More

Published Date: JAN-2026 | No Of Pages:176 | $ 4485

Bacterial Vaginosis Treatment Market By Treatment Type (Antibiotic Treatments, Probiotics-based Therapy, Topical Treatments, Oral Medications); By End-User (Hospitals & Clinics, Retail Pharmacies, Online Platforms, Diagnostic Imaging Centers, Gynecologists & General Practitioners); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bacterial Vaginosis Treatment Market will witness steady growth, with a projected CAGR of 5.5% from 2024 to 2030. The market was valued at approximately USD 1.3 bi... Read More

Published Date: JAN-2026 | No Of Pages:176 | $ 4485

Asperger Syndrome Treatment Market By Treatment Type (Behavioral and Psychological Therapy, Speech and Occupational Therapy, Pharmacological Management, Digital Therapeutics and Assistive Technologies); By Age Group (Children, Adolescents, Adults); By End User (Multidisciplinary Specialty Clinics, Hospitals and Diagnostic Centers, Educational Institutions, Home-Based and Teletherapy Platforms); By Geography, Segment Revenue Estimation and Forecast, 2026–2032

Asperger Syndrome Treatment Market: Mental Health Care, Adult Diagnosis, and Multidisciplinary Services Reshape Commercial Demand

The Global Asperger Syndrome Treatment Market was valued at USD 2.41 billion in 2025 and is projected to reach USD 3.67 billion by 2032, e... Read More

Published Date: JUL-2026 | No Of Pages:157 | $ 4485

Arteriovenous Malformations Market By Treatment Type (Embolization, Stereotactic Radiosurgery, Microsurgical Resection, Pharmacological Management); By Diagnostic Modality (DSA, MRI/MRA, CT Angiography, Functional Imaging); By Anatomical Location (Cerebral AVMs, Spinal AVMs, Peripheral AVMs, Visceral AVMs); By End User (Tertiary Hospitals, Academic Centers, General Hospitals, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Arteriovenous Malformations (AVM) Market is projected to grow at a 6.4% CAGR, rising from USD 2.7 billion in 2024 to USD 4.1 billion by 2030, driven by neurovascular treat... Read More

Published Date: JAN-2026 | No Of Pages:170 | $ 4485

Aplastic Anemia Treatment Market By Treatment Type (Immunosuppressive Therapy, Bone Marrow Transplantation, Supportive Care, Others); By Drug Class (Anti-thymocyte Globulin [ATG], Cyclosporine, Eltrombopag, Others); By End User (Hospitals, Specialty Clinics, Research & Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Aplastic Anemia Treatment Market is projected to grow at a robust 8.9% CAGR, rising from USD 1.32 billion in 2024 to nearly USD 2.19 billion by 2030, driv... Read More

Published Date: JAN-2026 | No Of Pages:180 | $ 4485

Stuttering Treatment Market By Treatment Type (Speech Therapy, Digital & App-Based Therapy, Pharmacological Treatment, Assistive Devices & Wearables); By Age Group (Children, Adolescents, Adults); By End User (Speech & Language Clinics, Hospitals & Rehabilitation Centers, Schools & Educational Institutions, Direct-to-Consumer Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Stuttering Treatment Market is forecast to grow at CAGR of 6.8%, increasing from USD 3.1 billion in 2024 to nearly USD 4.6 billion by 2030, fueled by Read More

Published Date: JAN-2026 | No Of Pages:157 | $ 4485

Radiodermatitis Market By Product Type (Topical Agents, Oral Medications, Dressings and Hydrogel Pads, Barrier Films and Sprays, Radioprotective Drugs); By Stage of Severity (Grade 1, Grade 2, Grade 3+); By End User (Hospitals, Specialty Dermatology Clinics, Ambulatory Radiation Centers, Retail Pharmacies & Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Radiodermatitis Market is poised for steady expansion at a CAGR of 6.3%, valued at USD 488.1 million in 2024 and projected to hit USD 746.2 million by 2030Read More

Published Date: JAN-2026 | No Of Pages:195 | $ 4485

Soft Tissue Sarcoma Treatment Market By Treatment Type (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Immunotherapy); By Disease Subtype (Gastrointestinal Stromal Tumors, Liposarcoma, Leiomyosarcoma, Others); By End User (Hospitals & Specialty Cancer Centers, Academic & Research Institutes, Ambulatory & Outpatient Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Soft Tissue Sarcoma Treatment Market is valued at USD 4.7 billion in 2024, and it is projected to reach USD 7.9 billion by 2030, reflecti... Read More

Published Date: JAN-2026 | No Of Pages:153 | $ 4485

Polymyalgia Rheumatica Treatment Market By Drug Class (Corticosteroids, Immunosuppressants, Biologics); By Route of Administration (Oral, Parenteral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Polymyalgia Rheumatica Treatment Market will witness a moderate CAGR of 5.6%, valued at USD 1.32 billion in 2024 and projected to reach USD 1.84 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:160 | $ 4485

Hereditary Transthyretin Amyloidosis Market By Treatment Type (TTR Stabilizers, Gene Silencing Therapies, Symptomatic Treatments); By Diagnostic Method (Genetic Testing, Imaging, Biomarker Testing); By End User (Hospitals, Specialty Clinics, Diagnostic Imaging Centers, Research Institutions); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hereditary Transthyretin Amyloidosis Market is valued at approximately USD 1.2 billion in 2024 and is expected to grow to USD 2.5 billion by 2030, representing a robust Read More

Published Date: JAN-2026 | No Of Pages:163 | $ 4485

Hypoparathyroidism Treatment Market By Drug Type (Calcium Supplements, Vitamin D Analogs, Recombinant PTH Therapies); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hypoparathyroidism Treatment Market is projected to grow at a CAGR of 8.1%, valued at USD 1.14 billion in 2024 and expected to reach USD 1.82 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:176 | $ 4485